A2M	alpha2macroglobulin
AMEe	S-Adenosylmethionine
APO-F	Plasmatic apolipoprotein
AUROC	Area Under the Receiver Operating Characteristics
ALT	alanine aminotransferase
AST	aspartate aminotransferase
BCAA	Brached chain aminoacid
BMI	Body mass index
CAP	Controlled attenuated parameter
CHI3L	chitinase 3-like protein 1
CK18	Cytokeratin 18
ELF	Enhanced Liver Fibrosis panel
ECM	Extracellular matrix turnover
FIB-4	Fibrosis Index-4
F3/F4	Fibrosis stage 3 /4
FGF21 gene	Fibroblast growth factor gene
FLI	Fatty liver Index
FXR	Farnesoid X receptor
GGT	gammaglutamil transferase
HA	Hyaluronic acid
HIS	Hepatic Steatosis Index
H-MRS	Magnetic resonance spectroscopy
KPa	KiloPascal
IL-8	interleukin 8
LC-MS	Liquid chromatography-Mass spectrometry
LFQP	label free quantitative proteomics approach
LncRNA	long non codingRNA
MAF	Minor allele frequency
MBOAT7	Membrane-bound O-acyltransferase domain-containing protein 7
MRI-PDFF	Magnetic resonance imaging-proton density fat fraction
MRE	Magnetic Resonance elastography
MRI	Magnetic Resonance Imaging
miRNA	microRNA
NAFLD	Non alcoholic fatty liver disease
NLFS	NAFLD Liver Fat score
NASH	Non alcoholic steatohepatitis
NASHTest	Non alcoholic steatohepatitis test
NPV	negative predictive value
PLT	platelets
PNPLA3	Patatin-like phospholipase domain-containing protein 3
PPV	Positive predictive value
pSWE	Point shear wave elastography
Pro-C3	Pro-ollagen III
sCD	soluble macrophage activation marker
T2DM	type 2 diabetes mellitus
TE	Transient Elastography
TIMP1	Metallopeptidase inhibitor 1
TGs	tryglicerides
TM6F2	Transmembrane 6 superfamily mamber 2
TNF	tumor necrosis factor
TyG	Triglyceride and Glucose Index
US	ultrasound
VAI	Visceral Adiposity Index